Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Tumor Cell Heterogeneity Folder Title: Hetero Updated: February 25, 2013 See Chapter 13 in Weinberg’s Biology of Cancer: pp. 527 to 556, Heterotypic Interactions Selected Molecular and Phenotypic Characteristics of Cancer Cells: Cancer Cells Are, Have, Can, or Show: Embryonic, Undifferentiated Large Nucleus, Excess DNA Defects in DNA Repair Secrete Proteases for Invasion Aberrant Mitoses Rapid Cell Division Anchorage-independent growth and cytoskeletal anomalies Failure to senesce (to exhibit ageing) Failure to invoke Apoptosis Invasive Metastatic Induce host cell support Selected Molecular and Phenotypic Characteristics of Cancer Cells: Ideas for Therapy Cancer Cells Are, Have, Can, or Show: Embryonic, Undifferentiated Large Nucleus, Excess DNA Defects in DNA Repair Secrete Proteases for Invasion Aberrant Mitoses Rapid Cell Division Anchorage-independent growth and cytoskeletal anomalies Failure to senesce (to exhibit ageing) Failure to invoke Apoptosis Invasive Metastatic Induces host cell support For Therapy we Can: Induce differentiation DNA-directed Anticancer Agents & XRay DNA-directed Anticancer Agents & Xray Protease Inhibitors Mitotic Poisons Anti-proliferative agents Cytoskeletal-directed agents: Microtubule and microfilament-directed Inhibit telomerase Activate Cell-death programs Inhibit proteolytic activity, inflammatory activity and motility Inhibit seeding at distant sites Inhibit angiogenesis and other host responses supporting tumor growth What If Different Cancer Cells within the Cancer in a single patient respond differently from one another? Handout: Science, February 1, 2013 Volume 339, pages 528-529 “Cancer Cell Phenotypes, in Fifty Shades of Grey” Science Perspective in Cancer Distinct Clonal Populations within a single tumor respond to signals and to chemotherapy differently from one another leading to differential clonal evolution and clonal survival . These differences are not based solely on genetic heterogeneity. Epigenetic differences and tumor micro-environment affect clonal heterogeneity. Other unknown factors may support heterogeneity. See accompanying research article conclusions, pp 543 to 548. Differences Among Tumors in Different Patients • Different Organ Site and Cell of Origin • Differences based on Sex, Age, Hormonal Status • Differences Based on Genetic Variations Among Hosts Differences Within a Tumor in a Single Patient • Progressive Overall Changes During Tumor Development • Temporal Changes Involving Cycling and NonCycling Cells • Changes Involving Host Cell Infiltration • Differences Based on Host Cell and Tissue Infiltration and Cancer Cell – Host Cell Interaction With respect to: Differences Based on Host Cell and Tissue Infiltration: Respect Thy Neighbor: Stromal Cell Interactions in Cancer (Principles only. No intent to memorize signaling pathways) This will come up as a print file outside of Powerpoint http://tpfondy.syr.edu/bio501/501Persons/scans/Stromal&Cx.pdf Tumor Heterogeneity in a Single Cancer in a Single Patient Heritable Differences Among Cells within a Single Neoplasm Derived from a Single Original Cell Lineage At a Single Given Time in Tumor Progression Producing Distinct Sub-Populations of Cells • Based on Generation of Genetic Differences • Based on Alterations in Phenotypic Expression Importance of Heterogeneity • Interaction of Sub-Populations in Growth Control • Generation of Metastatic Sub-Populations • Differences in Chemotherapeutic Susceptibility • Generation of Drug Resistant SubPopulations • Immunological Variations Extent of Heterogeneity Found in Experimental and Spontaneous Animal Tumors • In Long-Passaged Lines • In Tumors of Recent Origin Found in Clinical Human Cancers Tumors of Every Major Histological Type Found in Chemically, Virally, and Radiationinduced Tumors Properties That Are Heterogeneous Morphology Histology Karyotype Growth Rate Cell Products Receptors Enzymes Immunology Invasive & Metastatic Properties Signaling Pathway Anomalies Pathobiology in Patients Possible Sources of Tumor Cell Heterogeneity Heterogeneity of tumor cells originally transformed Differences in Inter-cellular Environments • During transformation • During progression Inherent Genetic Instability and Selection of Variants Cellular Anaplasia and Aberrant Cell Function In Vivo Host-Based Effects Fusion of Different Cells • Neoplastic and Normal Host Cell fusion • Fusion of neoplastic cells Cell Selection during Drug Treatment Pleural effusion, non-small cell lung carcinoma in a patient. Heterogeneity in chromosome number and in nuclear size Figure 11.19 The Biology of Cancer (© Garland Science 2007) p. 422 Chromosome 11 is Blue-Green. Chromosome 17 is pink by FISH with DNA Probes News Stories on Cancer: Incidence and Treatment Beads and Cancer Chemotherapy: A Creative Way to Cope with Cancer http://centralny.ynn.com/content/top_stories/537100/a-creative-way-to-cope-with-cancer/ Obesity and Cancer: ABC Evening News, Feb. 16, 2011 http://abcnews.go.com/WNT/video/obesity-crisis-threatens-health-care-system-americans-exercise-foodadvice-tips-health-12935370 Obesity and Medical Costs, ABCNEWS, Feb. 16, 2011 ObesityABC16Feb11.doc Colonoscopy: Feb. 22, 2012 http://www.nytimes.com/2012/02/23/health/colonoscopy-prevents-cancer-deaths-studyfinds.html?_r=1&hp ColonoscopyNYT_22Feb12.doc Tough Question. No cheating! I am still here! 1. Yes 2. No! 3. Not Sure 0% o! re 0% N ot Su N Y es 0% 0 of 96 On a scale of 1 to 5 rate (This will be set for anonymous) 1. I’m totally snowed 2. I’m having a hard time following 3. I’m doing OK with most of it. I can figure the rest out later. 4. I’m not having any problem following this. 5. This is not challenging enough for a 500 level course. Please get moving! 0 of 96 Based on the cell signaling pathway showing a bivalent external growth factor transmitting a signal into the interior of a cell through binding two receptor molecules in the membrane of the cell: Can you think of a general approach you might use to stop this signal pathway from working? ______________________________________ (you can abbreviate. I’ll do my best to figure out what you mean) If you can’t think of any approaches please type in “no” or “no ideas”. You will still get partial credit for today’s in-class quiz based on a earlier Turning Point question (I am here!). 0 of 5